A multicopy transposase-targeted qPCR assay for highly sensitive diagnosis of scrub typhus

This study presents "TranScrub," a highly sensitive and specific SYBR Green-based qPCR assay targeting a multicopy transposase gene that outperforms conventional single-copy gene methods for diagnosing scrub typhus in both blood and dried blood spot samples.

The Gist

The Problem: The "Ghost" in the Room

Imagine Scrub Typhus as a sneaky burglar who breaks into your body (causing fever and illness) but leaves very few clues. Doctors often struggle to catch this burglar because the symptoms look like many other common illnesses, and the classic "burglar mark" (an eschar or scab) is missing in many cases.

For a long time, the tools doctors used to find this burglar were like flashlights with weak batteries. They could find the burglar if he was standing right in front of them (high bacterial load), but if he was hiding in the shadows (low bacterial load), the flashlight couldn't see him. This led to many missed diagnoses.

The Old Tools: Looking for a Single Fingerprint

Most previous tests tried to find a specific "fingerprint" of the bacteria, a gene called 56kDa.

• The Analogy: Imagine the bacteria is a library. The 56kDa gene is like one single book in that library. If the library is small, or if that one book is hidden behind a stack of papers, your search might fail. You only have one chance to find it.

The New Solution: The "Transposase" Treasure Hunt

The researchers in this paper decided to stop looking for that single book. Instead, they looked for something the bacteria has in hundreds of copies. They found a specific gene called a transposase.

• The Analogy: Think of the bacteria's genome as a library again. The transposase gene isn't just one book; it's like 400 identical copies of the same popular novel scattered all over the shelves.
• The New Test (TranScrub): The researchers built a new detector (a qPCR assay) specifically designed to hunt for these 400 copies.
  • If you are looking for one book, you might miss it.
  • If you are looking for 400 copies of the same book, it is almost impossible to miss them. Even if the burglar is hiding in a tiny corner, the sheer number of copies makes him easy to spot.

How They Tested It

The team put their new "Super-Flashlight" (TranScrub) to the test against the old "Weak Flashlight" (56kDa) and another "Multi-Book" flashlight (called traD).

1. The Results:

   • They tested blood samples from 32 confirmed patients.
   • The Old Flashlight only found 11 patients.
   • The New Super-Flashlight found 29 out of 32 patients.
   • It was just as good as the other "Multi-Book" test but had a major bonus: it didn't get confused by other bacteria (no "false alarms").

2. The Sensitivity (How faint a signal can it see?):

   • The new test is incredibly sensitive. It can detect the bacteria even when there is only 0.024 copies of the genome in a drop of blood.
   • Analogy: If the old test needed a whole bucket of water to see a fish, the new test can see a single fish in a swimming pool.

3. The Field Test (Dried Blood Spots):

   • They also tested this on Dried Blood Spots (DBS). Imagine taking a tiny drop of blood, putting it on a piece of paper (like a stamp), and letting it dry. This is great for remote villages where you can't keep blood cold.
   • The new test worked perfectly on these dried paper spots, proving it can be used by doctors in the middle of a jungle or a remote farm.

Why This Matters

This new test is like upgrading from a magnifying glass to a high-powered telescope.

• Earlier Detection: Because it is so sensitive, it can catch the infection earlier, before the patient gets sicker.
• Fewer Missed Cases: It stops doctors from guessing and helps them treat the right patients with the right antibiotics immediately.
• Field Ready: It works on simple dried blood samples, meaning it can be used in remote areas without fancy labs.

The Bottom Line

The researchers found a "golden ticket" gene inside the Scrub Typhus bacteria that exists in hundreds of copies. By building a test that hunts for these copies, they created a tool that is faster, more sensitive, and more reliable than anything currently available. It's a game-changer for saving lives in tropical regions where this disease is common.

Technical Summary

1. Problem Statement

• Clinical Challenge: Scrub typhus, caused by the obligate intracellular bacterium Orientia tsutsugamushi, is a major cause of undifferentiated febrile illness in tropical and temperate regions. It is frequently underdiagnosed due to non-specific symptoms and the frequent absence of the characteristic eschar.
• Diagnostic Limitations:
  • Serology: Tests like IFA and ELISA often fail to detect infection in the early acute phase because antibody responses take time to develop.
  • Molecular Assays: Existing qPCR assays typically target single-copy genes (e.g., 56kDa, 47kDa, groEL, 16S rRNA). While specific, their sensitivity is limited by the low genomic copy number of these targets, leading to false negatives, especially when bacterial load is low.
  • Multicopy Targets: While the multicopy gene traD has shown promise, its performance in human clinical specimens has been inconsistent, and some versions exhibit cross-reactivity with other pathogens.

2. Methodology

The study aimed to develop and validate a novel, ultra-sensitive SYBR Green-based qPCR assay named TranScrub.

• Target Selection: The researchers targeted the transposase genes of O. tsutsugamushi. These genes are part of the Rickettsiales amplified genetic elements (RAGE) and exist in high copy numbers (estimated >400 copies) across the genome.
• Primer Design:
  • Primers (Trans-F and Trans-R) were designed using genomic sequences from 16 diverse O. tsutsugamushi strains (e.g., Karp, Kato, Gilliam, Boryong).
  • The design ensured broad coverage, predicting amplification sites across multiple strains with amplicon sizes of 135–145 bp.
• Assay Development:
  • Platform: SYBR Green qPCR on a Bio-Rad CFX96 system.
  • Comparison: TranScrub was compared against two established assays: the single-copy 56kDa assay and the multicopy traD assay.
• Validation Cohorts:
  • Sensitivity: Tested on 32 buffy coat samples from patients with confirmed scrub typhus (defined by ≥4-fold serological rise in IgM/IgG or positive 56kDa qPCR).
  • Specificity: Tested on 77 healthy donor blood samples.
  • Cross-reactivity: Evaluated against a panel of 15 blood-borne pathogens (including Plasmodium, Borrelia, Ehrlichia, and various bacteria) and human DNA.
  • Limit of Detection (LOD): Determined using serial dilutions of a confirmed positive sample quantified by digital PCR (dPCR) targeting the single-copy 47kDa gene.
  • Field Application: Tested on 81 archived Dried Blood Spot (DBS) samples from patients with acute febrile illness of unknown etiology. Positive results were confirmed via Oxford Nanopore amplicon sequencing.

3. Key Contributions

• Novel Target: First successful development and clinical validation of a qPCR assay targeting the highly repetitive transposase gene family for scrub typhus diagnosis.
• Enhanced Sensitivity: Demonstrated that targeting multicopy transposase genes significantly outperforms the conventional single-copy 56kDa target.
• Improved Specificity: Unlike the traD assay, which showed cross-reactivity with Acinetobacter baumannii, Leishmania tropica, and Ehrlichia chaffeensis, the TranScrub assay showed zero cross-reactivity with the tested panel of pathogens.
• Field Applicability: Validated the assay's utility on Dried Blood Spots (DBS), a critical sample type for surveillance in resource-limited, remote settings.

4. Results

• Sensitivity:
  • TranScrub: Detected 29/32 confirmed cases (91% sensitivity; 95% CI: 76–97%).
  • traD Assay: Also detected 29/32 cases (91% sensitivity).
  • 56kDa Assay: Detected only 11/32 cases (34% sensitivity).
  • Conclusion: Multicopy targets (TranScrub and traD) are significantly more sensitive than single-copy targets.
• Specificity:
  • TranScrub achieved 100% specificity (77/77) with no false positives in healthy donors.
  • No cross-reactivity was observed with any of the 15 tested blood-borne pathogens.
• Limit of Detection (LOD):
  • The LOD was calculated at 0.024 genome equivalents/µL.
  • This represents approximately a 100-fold improvement in sensitivity compared to reported LODs for 56kDa-based assays.
• DBS Performance:
  • TranScrub detected O. tsutsugamushi in 7.5% (6/81) of DBS samples from febrile patients.
  • All 6 positive DBS samples were confirmed by Oxford Nanopore sequencing, with >99% of reads mapping to the transposase gene.
  • Four of the six DBS positives were also detected by the traD assay.

5. Significance

• Clinical Impact: The TranScrub assay enables earlier and more reliable detection of scrub typhus, particularly during the acute phase when bacterial loads are low and serology is negative. This facilitates timely antibiotic treatment, potentially reducing the high case fatality rates (1–35%).
• Surveillance Utility: The ability to use DBS samples makes this assay ideal for large-scale epidemiological studies and surveillance in remote, resource-limited areas where venous blood collection and cold-chain storage are difficult.
• Diagnostic Workflow: The assay offers a robust alternative to the traD assay, providing comparable sensitivity but superior specificity (no cross-reactivity), making it a preferred tool for diagnostic workflows where co-infections with other pathogens are common.
• Future Directions: The authors suggest that further sensitivity improvements could be achieved by introducing a template fragmentation step (e.g., restriction enzyme digestion) to ensure multiple target copies from a single chromosome enter the reaction as separate molecules.

Conclusion: The TranScrub assay represents a significant advancement in molecular diagnostics for scrub typhus, leveraging genomic abundance to overcome the sensitivity limitations of current standards, while maintaining high specificity and adaptability for field surveillance.